Why Amazon Acquired PillPack

Why Amazon Acquired PillPack

By

May. 4 2021, Updated 10:09 a.m. ET

Amazon targets pharmaceutical market with PillPack acquisition

It seems the overall tech sector (QQQ) is on an acquisition spree. On June 28, Amazon (AMZN) announced its acquisition of PillPack, an online pharmacy that organizes, packages, and delivers medicines and drugs.

Though Amazon hasn’t divulged the financial details of the deal, according to CNBC, Amazon has paid $1 billion to acquire PillPack. According to its website, PillPack is licensed to ship medicines in 49 states. The deal is expected to close later in 2018.

Article continues below advertisement

PillPack’s funding and target market

Founded in 2013, PillPack has until now raised $117.8 million in five rounds of funding from Atlas Venture, CRV, and Accel Partners, as reported by Crunchbase.

At PillPack, drugs are sent to consumers in packages with all the necessary details, such as the number of medications and when they should be taken. Customers can order from PillPack’s online pharmacy, and customized packets will be delivered to their front door.

The service targets consumers who are on multiple medications. PharmacyOS, which is PillPack’s software, enables the presorting of pills, the easy tracking of prescriptions, the management of refills, communication with patients, and shipping.

On PillPack’s acquisition, Jeff Wilke, CEO of Amazon Worldwide Consumer, said, “PillPack’s visionary team has a combination of deep pharmacy experience and a focus on technology.”

Advertisement

More From Market Realist

  • A "now hiring" sign outside a Popeyes restaurant, one sign that employers are having trouble finding employees willing to work for current wages.
    Consumer
    Why Employers Are Struggling To Fill Jobs Despite High Unemployment
  • Beyond Meat patties in a grocery cart
    Consumer
    Buying the Dip on Beyond Meat (BYND) Stock Is a Risky Move
  • People looking at data on a laptop
    Consumer
    Is Driven Brands (DRVN) a Good Stock to Buy? A Look at the Year Ahead
  • A Moscow Mule drink made with Reed's
    Consumer
    Is Reed's (REED) a Good Stock to Buy? A Look at the Year Ahead
  • CONNECT with Market Realist
  • Link to Facebook
  • Link to Twitter
  • Link to Instagram
  • Link to Email Subscribe
Market Realist Logo
Do Not Sell My Personal Information

© Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.